首页> 外文会议>Annual Veterinary Medical Forum >Pyrimethamine-sulfonamide dosage and treatment duration recommendations for equine protozoal myeloencephalitis: findings from a retrospective
【24h】

Pyrimethamine-sulfonamide dosage and treatment duration recommendations for equine protozoal myeloencephalitis: findings from a retrospective

机译:吡米甲胺 - 磺酰胺剂量和治疗持续时间推荐,用于马前生髓鞘性脑炎:从回顾性的调查结果

获取原文

摘要

The most important aspect of therapy for equine protozoal myeloencephalitis (EPM) is antibiotics directed against the parasite. Additional treatment may also be necessary, including anti-inflammatory medication to eliminate inflammation of the affected nervous tissue, treatment of any secondary problems, and supplementation to offset any potential side effects of the antibiotic treatment. Antibiotic recommendations for EPM were originally proposed as empiric dosages of pyrimethamine, trimethoprim and sulfadiazine. The basis for these recommendations was the use of these drugs for treatment of malaria and toxoplasmosis in humans. Pyrimethamine, in combination with trimethoprim and either sulfadiazine or sulfamethoxazole, has been used with some success and gained widespread acceptance as the treatment of choice.
机译:马来子原生动物髓鞘炎(EPM)的最重要方面是针对寄生虫的抗生素。还可能需要额外的治疗,包括消除抗炎药物,以消除受影响的神经组织的炎症,治疗任何二次问题,并补充抵消抗生素治疗的任何潜在副作用。 EPM的抗生素建议最初是作为吡米甲胺,TrimethOlim和磺胺嗪的经验剂量。这些建议的基础是使用这些药物治疗人类的疟疾和弓形虫病。与Trimethokim和磺胺噻嗪或磺胺甲恶唑组合的吡米甲磺酸吡喃胺已被一些成功使用,并且获得了广泛的接受作为选择的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号